Rare Disease Report

Oncology Expert Explains Why These Are Exciting Times in Rare Cancers

DECEMBER 11, 2017
Gerald Messerschmidt, M.D., FACP
Gerald Messerschmidt, M.D., FACP, Chief Medical Officer at Precision Oncology, has worked in the cancer field for almost four decades.

In this interview from the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, he tells Rare Disease Report why the recent surge in U.S. Food and Drug Administration activity pertaining to rare cancer types is no fluke, and how patients can see long-term survival from breakthrough therapies, and how far the community has come from the National Institute of Health's (NIH) Human-Genome project from the 1990's.


For more from ASH, follow Rare Disease Report on Facebook and Twitter.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.